Johnson & Johnson (JNJ) Cost of Revenue (2009 - 2026)
Johnson & Johnson's Cost of Revenue came in at $8.05 billion for Q2 2026, up 5.5% from $7.63 billion a year earlier but down 0.7% from the prior quarter.
Powered by 
Analysis
Johnson & Johnson (JNJ) Cost of Revenue (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 28, 2026, Johnson & Johnson reported Cost of Revenue of $31.43 billion, up 8.1% year-over-year; for FY2025, it was $30.26 billion, up 10.1% from FY2024.
- Cost of Revenue has increased in each of the last three years, with a four-year compound annual growth rate of 1.6% (FY2021 to FY2025).
- Going back by year, Cost of Revenue was $27.47 billion in FY2024 (+3.5%), $26.55 billion in FY2023 (+8.0%), $24.6 billion in FY2022 and $28.43 billion in FY2021.
- The five-year range for quarterly Cost of Revenue is $2.7 billion (Q4 2022) to $8.11 billion (Q1 2026).
- Year-over-year, Cost of Revenue has increased for nine consecutive quarters, with growth averaging 8.3% over the last eight quarters.
- The fastest year-over-year change in Cost of Revenue over five years came in Q4 2023 (growth of 152.2%), and the weakest in Q1 2024 (a decline of 2.6%).
- Business Quant data shows JNJ's Cost of Revenue at $8.11 billion (Q1 2026), $7.97 billion (Q4 2025) and $7.3 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.27 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 8.05 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 4.29 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 4.40 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 3.71 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 2.52 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 2.81 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.58 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 4.09 Bn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 489.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 8.05 Bn |
| Mar 29, 2026 | 8.11 Bn |
| Dec 28, 2025 | 7.97 Bn |
| Sep 28, 2025 | 7.30 Bn |
| Jun 29, 2025 | 7.63 Bn |
| Mar 30, 2025 | 7.36 Bn |
| Dec 29, 2024 | 7.13 Bn |
| Sep 29, 2024 | 6.96 Bn |
| Jun 30, 2024 | 6.87 Bn |
| Mar 31, 2024 | 6.51 Bn |
| Dec 31, 2023 | 6.80 Bn |
| Oct 1, 2023 | 6.61 Bn |
| Jul 2, 2023 | 6.46 Bn |
| Apr 2, 2023 | 6.69 Bn |
| Jan 1, 2023 | 2.70 Bn |
| Oct 2, 2022 | 6.17 Bn |
| Jul 3, 2022 | 7.92 Bn |
| Apr 3, 2022 | 7.60 Bn |
| Oct 3, 2021 | 7.25 Bn |
| Jul 4, 2021 | 7.59 Bn |
API Access
Johnson & Johnson Cost of Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=JNJ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cost-of-revenue", "ticker": "JNJ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cost-of-revenue&ticker=JNJ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();